Companies: 49,246 Total Market Cap: 132386205533959.40

Zentiva, a.s.

BSSE-1SKF401E
Pharmaceutical Preparations
Rank #28478
Market Cap 54.81 M
Volume 2
Price 33.83
Change (%) 0.00%
Country or region Slovakia Slovakia

Zentiva, a.s.'s latest marketcap:

54.81 M

As of 05/20/2025, Zentiva, a.s.'s market capitalization has reached $54.81 M. According to our data, Zentiva, a.s. is the 28478th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 54.81 M
Revenue (ttm) 40.79 M
Net Income (ttm) 2.58 M
Shares Out 1.62 M
EPS (ttm) 1.59
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date n/a
Market Cap Chart
Data Updated: 05/20/2025

Zentiva, a.s.'s yearly market capitalization.

Zentiva, a.s. has seen its market value drop from €145.82 M to €48.61 M since 2020, representing a total decrease of 66.67% and an annual compound decline rate (CAGR) of 21.90%.
Date Market Cap Change (%)
05/20/2025 €48.61 M -3.23%
12/11/2024 €50.23 M 3.33%
12/20/2023 €48.61 M 20%
11/24/2022 €40.50 M -17.76%
12/17/2021 €49.25 M -66.22%
12/09/2020 €145.82 M

Company Profile

About Zentiva, a.s.

Zentiva, a.s. is a leading pharmaceutical company specializing in the development, manufacturing, and sale of generic medicinal products. Primarily serving the primary care sector, the company operates in Slovakia, the Czech Republic, and internationally.

Product Portfolio

The company offers a diverse range of prescription medicines, including:

  • Lipid-lowering agents
  • Hypotensives
  • Sympatholytics
  • Prokinetics
  • Vitamins
  • Antipyretics
  • Beta-blockers
  • Otorhinolaryngological products
  • Antidiabetics
  • Antihistamines

With 56 pharmaceutical forms available in Slovakia, Zentiva ensures a broad and accessible healthcare solution.

Business Activities

In addition to pharmaceutical sales, Zentiva engages in:

  • Production of pharmaceuticals and chemical products
  • Wholesale distribution of medical supplies

Corporate Background

Originally established as Slovakofarma, a.s., the company rebranded to Zentiva, a.s. in 2003. Founded in 1992 and headquartered in Bratislava, Slovakia, Zentiva operates as a subsidiary of ZENTIVA PHARMA GMBH.

Frequently Asked Questions

As of 05/20/2025, Zentiva, a.s. (including the parent company, if applicable) has an estimated market capitalization of $54.81 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Zentiva, a.s. global market capitalization ranking is approximately 28478 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Slovakia
Founded 1992
IPO Date n/a
Employees 90
CEO
Sector
Industry Pharmaceutical Preparations
Address Einsteinova 24
Bratislava, 851 01
Slovakia
Website https://www.zentiva.sk
People Also Watch
Ipsen S.A.
138.21 0.00%
Krka, d. d.
209.75 0.00%
BUD-RICHTER
29.11 0.00%
Hugel
244.93 0.00%